The Vaxaas nano patch may well be used in the next trials. That would be an interesting validation of both technologies.
I wonder what the commercials around that might look like? Would we be the first significant use?
Trials will at some point need to be on the whole system, not just the vaccine. I'm intrigued if that will start from phase 2b.
The Vaxaas nano patch may well be used in the next trials. That...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.25 |
Change
0.000(0.00%) |
Mkt cap ! $295.9M | |||
| Open | High | Low | Value | Volume |
| $14.20 | $14.76 | $13.70 | $346.5K | 24.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 594 | $14.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.83 | 65 | 2 |
View Market Depth
| Last trade - 15.59pm 12/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |